4.2 Letter

Tocilizumab, Adipokines and Severe Complications of COVID-19

Journal

CLINICAL DRUG INVESTIGATION
Volume 40, Issue 9, Pages 891-892

Publisher

ADIS INT LTD
DOI: 10.1007/s40261-020-00950-2

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available